University Reproductive Associates
Hasbrouck Heights, New Jersey, 07604, United States
Location status: Recruiting
Location contact
Peter G. McGovern, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT02357654
During IVF cycles an embryo is generally placed into the uterine cavity between 3 and 5 days after fertilization. For a successful pregnancy to take place, that embryo must then implant in the properly primed and staged endometrium, which subsequently must continue to develop to accommodate the growing and maturing embryo and then fetus. This process is normally regulated by hormonal interactions between the fetal, endometrial and luteal tissue. It has been found that after IVF additional support for the endometrium with progesterone improves implantation and subsequent live birth rates in IVF cycle . Recent data has shown that additional supplementation with a single administration of a GnRH agonist around the time the time of embryo transfer may further enhance these rates .
Interested in participating?
Request Info18 year–40 year
Female
Interventional
Phase 4
Hasbrouck Heights, New Jersey, 07604, United States
Location status: Recruiting
Peter G. McGovern, MD
PRINCIPAL_INVESTIGATOR
see above
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
single shot of GnRH agonist
placebo
Time frame: 9 months
Time frame: 4 weeks
Time frame: 4 weeks
Time frame: 4 weeks
Contact information is provided by the study sponsor or research team.
University Reproductive Associates
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07226310
Genital Diseases, Infertility
Oklahoma City, Oklahoma, United States
View Trial DetailsNCT05440617
Acute Ovarian Failure, Early Menopause And Infertility In Females After Treatment For Childhood Cancer
Bethesda, Maryland, United States
View Trial DetailsNCT01500447
Amenorrhea, Congenital Abnormalities
Bethesda, Maryland, United States
View Trial DetailsNCT07340827
Genital Diseases, Infertility
Akita, Japan
View Trial Details